← Leaderboards
David Andrew Bull
University Of Utah
$3,607,454
Attributed
$3,607,454
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $726.7K · FY2005–11$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$3,607,454 · 2
By mechanism
R01$1,840,599 · 1
U01$1,766,855 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Utah
Same institution · by research overlap
- Sung Wan Kim$13,234,593
- Dean Yaw Li$21,127,919
- Elizabeth Ann Leibold$10,466,777
- Michael T Howard$4,752,416
- Yufeng Huang$2,833,943
Others in their field
Top investigators on “Polymers”
- Marc A Hillmyer · University Of Minnesota-Twin Cities$45,350,238
- Michael F Rubner · Massachusetts Institute Of Technology$44,168,921
- Nicholas Hud · Emory University$41,051,104
- Timothy P Lodge · Gordon Research Conferences$40,942,324
- Eric Baer · Case Western Reserve University$37,476,250
- Robert S Langer · Massachusetts Institute Of Technology$29,222,504
Research focus
PolymersVascular Endothelial Growth FactorsGene TherapyGene Delivery SystemSafetyBaseVegf GeneStagingGenesMyocardialIschemiaPoly(Ethylenimine)-Co-(N-(2-Aminoethyl) Ethyleneimin)-Co-N-(N-Cholesteryloxycarbonyl-(2-Aminoethyl)Ethylenimine)CardiacBone MarrowAngiogenesisAcademic Medical CentersClinical ResearchExpression VectorCommunity PracticeEnrollmentDestinationsCitiesColoradoCells
Grant awards (10)
Gene- and Cell-based therapies for LVAD patients$351,273
U01 · FY2011 · HL · contact PI
Gene- and Cell-based therapies for LVAD patients$351,273
U01 · FY2009 · HL · contact PI
Gene- and Cell-based therapies for LVAD patients$351,273
U01 · FY2008 · HL · contact PI
Polymer Carrier for Ischemia-Inducible Gene Therapy$354,382
R01 · FY2007 · HL · contact PI
Gene- and Cell-based therapies for LVAD patients$351,273
U01 · FY2007 · HL · contact PI
Polymer Carrier for Ischemia-Inducible Gene Therapy$364,967
R01 · FY2006 · HL · contact PI
Gene- and Cell-based therapies for LVAD patients$361,763
U01 · FY2006 · HL · contact PI
Polymer Carrier for Ischemia-Inducible Gene Therapy$373,750
R01 · FY2005 · HL
Polymer Carrier for Ischemia-Inducible Gene Therapy$373,750
R01 · FY2004 · HL
Polymer Carrier for Ischemia-Inducible Gene Therapy$373,750
R01 · FY2003 · HL